Agenus Inc (AGEN) – Strategy, SWOT and Corporate Finance Report
- Pages: 56
- Published: June 2023
- Report Code: MLPH4419FSA
Agenus Inc (AGEN) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company
Key Highlights
Agenus Inc (Agenus), formerly, Antigenics Inc, is a clinical-stage immuno-oncology company that discovers, develops and commercializes immunotherapeutics for the treatment of various types of cancers and infectious diseases. The company’s pipeline portfolio encompasses vaccines for glioblastoma, genital herpes, and multiple cancer types; vaccine adjuvants for the treatment of shingles and malaria; and checkpoint antibodies targeted at various diseases. The company's technology portfolio includes antibody discovery platform, vaccine platforms and Heat Shock Protein (HSP) platform. It operates in the US and Europe. Agenus is headquartered in Lexington, Massachusetts, the US.
Scope
• Detailed information on Agenus Inc required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Agenus Inc in the form of a SWOT analysis
• An in-depth view of the business model of Agenus Inc including a breakdown and examination of key business segments
• News about Agenus Inc, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
• Gain understanding of Agenus Inc and the factors that influence its strategies.• Track strategic initiatives of the company and latest corporate news and actions.
• Assess Agenus Inc as a prospective partner, vendor or supplier.
• Support sales activities by understanding your customers' businesses better.
• Stay up to date on Agenus Incs business structure, strategy and prospects.
Note: Some sections may be missing if data is unavailable for the company.
Companies mentioned
Janssen Pharmaceuticals Inc
Dynavax Technologies Corp
Amgen Inc
Maxinovel Pharmaceuticals
Biocad
Qilu Pharmaceutical Co Ltd
AbbVie Inc
3D Medicines Inc
CSPC ZhongQi Pharmaceutical Technology Co Ltd
Boehringer Ingelheim International GmbH
Arcus Biosciences Inc
SinoCelltech Group Ltd
Genor BioPharma Co Ltd
Shanghai Henlius Biotech Co., Ltd.
Novartis AG
MacroGenics Inc
Incyte Corp
Checkpoint Therapeutics Inc
MabSpace Biosciences (Suzhou) Co Ltd
ImmuneOncia Therapeutics Inc
Shandong New Time Pharmaceutical Co Ltd
TVAX Biomedical Inc
Green Cross Cell Corp
EOM Pharmaceuticals Holdings Inc
Northwest Biotherapeutics Inc
Celldex Therapeutics Inc
Juvaris BioTherapeutics Inc
Idera Pharmaceuticals Inc
Dynavax Technologies Corp
Oxford BioMedica Plc
Table of Contents
List of Tables
List of Figures
Pricing
Discounts available for multiple purchases.